Table 3.

Transplanted human ALDHhiCD133+Lin- cells retain primitive hematopoietic surface markers after repopulation in vivo


Transplanted cell population

CD34+, %

CD34+CD38+, %

CD34+CD38-, %

CD34+CD133+, %
ALDHhiCD133+Lin-  30.0 ± 4.7*  27.4 ± 4.7*  2.6 ± 0.3  6.8 ± 1.1 
CD133+Lin-  25.3 ± 4.0*  22.7 ± 3.6*  2.6 ± 0.6  6.1 ± 1.1 
ALDHhiLin-
 
14.0 ± 2.6*
 
13.8 ± 2.2
 
0.2 ± 0.1
 
1.5 ± 0.6
 

Transplanted cell population

CD34+, %

CD34+CD38+, %

CD34+CD38-, %

CD34+CD133+, %
ALDHhiCD133+Lin-  30.0 ± 4.7*  27.4 ± 4.7*  2.6 ± 0.3  6.8 ± 1.1 
CD133+Lin-  25.3 ± 4.0*  22.7 ± 3.6*  2.6 ± 0.6  6.1 ± 1.1 
ALDHhiLin-
 
14.0 ± 2.6*
 
13.8 ± 2.2
 
0.2 ± 0.1
 
1.5 ± 0.6
 

Mean expression of primitive cell surface markers after the transplantation of purified ALDHhiCD133+Lin- (n = 6) or CD133+Lin- (n = 5) cells was compared with BM repopulation produced by purified ALDHhiLin- cells (n = 5). Populations that received transplants of ALDHhiCD133+Lin- and CD133+Lin- retained cells that expressed CD34 and showed increased frequencies of CD34+CD38+ progenitors and CD34+CD38- repopulating cells.

*

P < .05

P < .001

P < .01

or Create an Account

Close Modal
Close Modal